Conditions: Gastroenteropancreatic Neuroendocrine Tumors
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 12
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the safety and tolerability of 68Ga-OPS202 used for the diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP NETs).

Detailed description:

Arms:
arm 1: Satoreotide trizoxetan will be administered in two sequentially ascending peptide doses

Interventions: intervention 1: satoreotide trizoxetan
Intervention descriptions: intervention 1: None

Protocol document: